Bausch & Lomb U.K Limited

Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
Telephone: +44 (0)208 781 2900
Fax: +44 (0)208 781 2901
Medical Information Direct Line: +44(0)1748 828849 or 08 1871 9318
Medical Information e-mail: medicalinformationuk@bausch.com
Customer Care direct line: +44 (0)208781 2991

Patient Information Leaflet last updated on the eMC: 23/02/2011
PIL Minims Proxymetacaine hydrochloride 0.5% w/v & Fluorescein sodium 0.25% w/v

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 20/05/2010 and displayed until 23/02/2011
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/09/2007 and displayed until 20/05/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/01/2004 and displayed until 14/09/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 14/06/2000 and displayed until 27/01/2004
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   fluorescein sodium
   proxymetacaine hydrochloride